SCM
SBBP

Stonebridge Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Stonebridge Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,950
Closed -$41K – 139
2019
Q2 		$41K Buy
12,950
+2,000
+18% +$7.34K 0.02% 134
2019
Q1 		$55K Buy
+10,950
New +$53.9K 0.02% 139

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stonebridge Capital Management's SBBP Position: Q3 2019 in Review

Stonebridge Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2019, closing a stake of 12,950 shares — an estimated $41K sold.

Stonebridge Capital Management first reported a position in SBBP in Q1 2019 and held it in 2 quarters. The position peaked at $55K in Q1 2019. 54 funds tracked by Wall St. Rank hold SBBP as of Q3 2019.

  • Stonebridge Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q3 2019 after selling out during the quarter.
  • Stonebridge Capital Management sold 12,950 Strongbridge Biopharma plc. shares in Q3 2019, an estimated $41K.
  • Stonebridge Capital Management first reported a position in Strongbridge Biopharma plc. in Q1 2019 and held it in 2 quarters.
  • Stonebridge Capital Management's Strongbridge Biopharma plc. position peaked at $55K in Q1 2019.
  • 54 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2019.

Based on Stonebridge Capital Management's 13F filing for Q3 2019, filed 2 Oct 2019.